276 related articles for article (PubMed ID: 26612091)
21. Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.
Gyöngyösi M; Wojakowski W; Lemarchand P; Lunde K; Tendera M; Bartunek J; Marban E; Assmus B; Henry TD; Traverse JH; Moyé LA; Sürder D; Corti R; Huikuri H; Miettinen J; Wöhrle J; Obradovic S; Roncalli J; Malliaras K; Pokushalov E; Romanov A; Kastrup J; Bergmann MW; Atsma DE; Diederichsen A; Edes I; Benedek I; Benedek T; Pejkov H; Nyolczas N; Pavo N; Bergler-Klein J; Pavo IJ; Sylven C; Berti S; Navarese EP; Maurer G;
Circ Res; 2015 Apr; 116(8):1346-60. PubMed ID: 25700037
[TBL] [Abstract][Full Text] [Related]
22. Durable Benefits of Cellular Postconditioning: Long-Term Effects of Allogeneic Cardiosphere-Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction.
Kanazawa H; Tseliou E; Dawkins JF; De Couto G; Gallet R; Malliaras K; Yee K; Kreke M; Valle I; Smith RR; Middleton RC; Ho CS; Dharmakumar R; Li D; Makkar RR; Fukuda K; Marbán L; Marbán E
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857066
[TBL] [Abstract][Full Text] [Related]
23. Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion.
Chan W; Duffy SJ; White DA; Gao XM; Du XJ; Ellims AH; Dart AM; Taylor AJ
JACC Cardiovasc Imaging; 2012 Sep; 5(9):884-93. PubMed ID: 22974800
[TBL] [Abstract][Full Text] [Related]
24. Cardioprotection: Where to from here?
Kloner RA; Hale SL; Dai W; Shi J
Cardiovasc Drugs Ther; 2017 Feb; 31(1):53-61. PubMed ID: 27714476
[TBL] [Abstract][Full Text] [Related]
25. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
26. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
[TBL] [Abstract][Full Text] [Related]
27. Effects of Intracoronary Infusion of Escalating Doses of Cardiac Stem Cells in Rats With Acute Myocardial Infarction.
Tang XL; Rokosh G; Sanganalmath SK; Tokita Y; Keith MC; Shirk G; Stowers H; Hunt GN; Wu W; Dawn B; Bolli R
Circ Heart Fail; 2015 Jul; 8(4):757-65. PubMed ID: 25995227
[TBL] [Abstract][Full Text] [Related]
28. Benefits of reperfusion beyond infarct size limitation.
Takemura G; Nakagawa M; Kanamori H; Minatoguchi S; Fujiwara H
Cardiovasc Res; 2009 Jul; 83(2):269-76. PubMed ID: 19176600
[TBL] [Abstract][Full Text] [Related]
29. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.
Atar D; Petzelbauer P; Schwitter J; Huber K; Rensing B; Kasprzak JD; Butter C; Grip L; Hansen PR; Süselbeck T; Clemmensen PM; Marin-Galiano M; Geudelin B; Buser PT;
J Am Coll Cardiol; 2009 Feb; 53(8):720-9. PubMed ID: 19232907
[TBL] [Abstract][Full Text] [Related]
30. Effect of infarct severity on regional and global left ventricular remodeling in patients with successfully reperfused ST segment elevation myocardial infarction.
Symons R; Masci PG; Goetschalckx K; Doulaptsis K; Janssens S; Bogaert J
Radiology; 2015 Jan; 274(1):93-102. PubMed ID: 25207466
[TBL] [Abstract][Full Text] [Related]
31. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
[TBL] [Abstract][Full Text] [Related]
32. The reduction of infarct size--forty years of research.
Ferreira R
Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
[TBL] [Abstract][Full Text] [Related]
33. Impact of time to therapy and presence of collaterals on the efficacy of FX06 in acute ST elevation myocardial infarction: a substudy of the F.I.R.E., the Efficacy of FX06 in the prevention of myocardial reperfusion injury trial.
Hallén J; Petzelbauer P; Schwitter J; Geudelin B; Buser P; Atar D
EuroIntervention; 2010 Apr; 5(8):946-52. PubMed ID: 20542780
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo.
Oerlemans MI; Liu J; Arslan F; den Ouden K; van Middelaar BJ; Doevendans PA; Sluijter JP
Basic Res Cardiol; 2012 Jul; 107(4):270. PubMed ID: 22553001
[TBL] [Abstract][Full Text] [Related]
35. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
[TBL] [Abstract][Full Text] [Related]
36. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
[TBL] [Abstract][Full Text] [Related]
37. [Metformin and left ventricular remodeling after acute myocardial infarction: molecular mechanisms and clinical implications].
Paneni F; Costantino S; Cosentino F
G Ital Cardiol (Rome); 2015 Apr; 16(4):225-31. PubMed ID: 25959758
[TBL] [Abstract][Full Text] [Related]
38. A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial infarction: Rationale and design of the PRESERVATION I trial.
Rao SV; Zeymer U; Douglas PS; Al-Khalidi H; Liu J; Gibson CM; Harrison RW; Joseph DS; Heyrman R; Krucoff MW
Am Heart J; 2015 Nov; 170(5):929-37. PubMed ID: 26542501
[TBL] [Abstract][Full Text] [Related]
39. [Effects of reperfusion arrhythmia on myocardial apoptosis and left ventricular remodeling in patients with acute myocardial infarction].
Wang SY; Chen J; Yang XC; Chi HJ; Liu XL
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jan; 35(1):59-62. PubMed ID: 17386168
[TBL] [Abstract][Full Text] [Related]
40. Concurrent microvascular and infarct remodeling after successful reperfusion of ST-elevation acute myocardial infarction.
Sezer M; Aslanger EK; Cimen AO; Yormaz E; Turkmen C; Umman B; Nisanci Y; Bugra Z; Adalet K; Umman S
Circ Cardiovasc Interv; 2010 Jun; 3(3):208-15. PubMed ID: 20484102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
